Register to leave comments

  • News bot Oct. 1, 2025, 2:44 p.m.

    📋 ALTIMMUNE, INC. (ALT) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 07:07:36

    Event Type: Financial Results

    Event Details:

    Altimmune Inc (ALT) Reports Q2 2022 Financial Results Altimmune Inc (ALT) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: 32
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 179981
      • expected in Q3 and Q4 2022
      • expected in Q3 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 5.04K 5.04K $0.00 +0.00%
    Current Assets Property Equipment Net 1.34K 1.34K $0.00 +0.00%
    Current Assets Intangible Assets Net 12.42K 12.42K $0.00 +0.00%
    Current Assets Other Assets 811.00 811.00 $0.00 +0.00%
    Current Liabilities Accounts Payable 2.21K 2.21K $0.00 +0.00%
    Current Liabilities Other Long Term Liabilities 1.67K 1.67K $0.00 +0.00%
    Revenue 32.00 32.00 $0.00 +0.00%
    Operating Expenses Loss From Operations -19.50K -19.50K $0.00 +0.00%
    Other Income Expense Interest Expense -62.00 -62.00 $0.00 +0.00%
    Other Income Expense Interest Income 21.00 21.00 $0.00 +0.00%
    Other Income Expense Total Other Income Expense 69.00 69.00 $0.00 +0.00%
    Other Income Expense Net Loss -19.43K -19.43K $0.00 +0.00%
    Other Income Expense Net Loss Per Share -0.44 -0.44 $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 5.04K 5.04K $0.00 +0.00%
    Property and Equipment, Net 1.34K 1.34K $0.00 +0.00%
    Intangible Assets, Net 12.42K 12.42K $0.00 +0.00%
    Other Assets 811.00 811.00 $0.00 +0.00%
    Accounts Payable 2.21K 2.21K $0.00 +0.00%
    Revenue 32.00 32.00 $0.00 +0.00%
    Loss from Operations -19.50K -19.50K $0.00 +0.00%
    Interest Expense -62.00 -62.00 $0.00 +0.00%
    Interest Income 21.00 21.00 $0.00 +0.00%
    Total Other Income/(Expense) 69.00 69.00 $0.00 +0.00%
    Net Loss -19.43K -19.43K $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Altimmune Inc
    • CIK: 0001326190
    • Ticker Symbol: ALT
    • Period End Date: 2022-05-12
    • Document Type: 8-K